NRXP
NRx Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$3.45
+0.58%Margins
Gross margin
32.7%
EBITDA margin
-647.1%
EBIT margin
-588.2%
Net margin
-691.8%
FCF margin
-609.0%
—
Return on equity
-68.7%
Return on assets
-1855.5%
Return on invested capital
0.15x
Asset turnover
-$19.8M
Cash from operations
$0.62
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026